Uncategorized

Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge – Reuters

Posted on Author Tim Hodges Comments Off on Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge – Reuters
  1. Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge  Reuters
  2. Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health  Yahoo Finance
  3. Lilly Dives As Zepbound Loses A Key Battle To Novo’s Wegovy  Investor’s Business Daily
  4. CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans  CNBC
  5. Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies  PR Newswire